Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06512415
NA

10 Vs.15 mcg Norepinephrine Bolus in Severe Maternal Hypotension During Cesarean Delivery

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

Data regarding the optimum dose of norepinephrine for management of severe maternal hypotension is lacking. A previous report showed that the use of 10-mcg norepinephrine bolus was not superior to the 5-mcg bolus in the management of severe hypotension in addition the incidence of reactive bradycardia and hypertension was comparable in the two doses. Therefore, we hypothesize that using a higher dose of norepinephrine (15 mcg) would increase the success rate of management of severe hypotensive episode.

Official title: Comparing 10- Versus 15-mcg Norepinephrine Bolus for Management of Severe Post-spinal Hypotension During Elective Cesarean Delivery: A Randomized, Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

184

Start Date

2024-08

Completion Date

2024-12

Last Updated

2024-07-22

Healthy Volunteers

No

Interventions

DRUG

10 mcg Norepinephrine

The assigned dose (10 mcg) will be diluted with normal saline in a 10-cc syringe

DRUG

15 mcg Norepinephrine

The assigned dose (15 mcg) will be diluted with normal saline in a 10-cc syringe.

Locations (1)

Cairo University

Cairo, Egypt